Submission of Voting Results and Scrutinizers Report for the 34th Annual General Meeting of the Company held on Tuesday, September 30, 2025
Awaiting price reaction for this filing.
Sarda Proteins Ltd held its 34th Annual General Meeting on September 30, 2025, via video conferencing, where all 4 resolutions were passed with the requisite majority. The resolutions included adopting the audited financial statements for FY ended March 31, 2025, re-appointing Mr. Chirag Shantilal Thumar as a director (retiring by rotation), appointing M/s. S. D. Mehta & Co. as statutory auditor, and approving M/s H. Togadiya and Associates as secretarial auditor for a 5-year term. Out of 17,25,900 total outstanding shares, only 1,26,285 shares (about 7.32%) were voted, with 100% of votes cast in favour of all resolutions and zero against. 52 shareholders attended the meeting through video conferencing out of 2,953 shareholders on record. Vijay Anadkat & Associates acted as the scrutinizer for the e-voting and poll process.
All resolutions passed unanimously with no dissenting votes, indicating no shareholder opposition on the financial statements, director re-appointment, or auditor appointments. The very low voting turnout (7.32%) suggests limited public shareholder engagement but is routine for a small-cap BSE-listed company.